Cloning of the gene for Chediak-Higashi syndrome

Chediak-Higashi 综合征基因的克隆

基本信息

  • 批准号:
    09470190
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Oculocutaneous albinism, giant inclusion bodies in many cell types, and immunodeficiency characterize Chediak-Higashi syndrome (CHS). Previously, others and we have mapped and cloned the gene for human CHS.In this study, we aimed to clone the whole gene and characterize the intron-exon organization of the gene and mutation analysis of the disorder.By marathon cDNA amplification method, we succeeded in cloning the whole gene for CHS.The gene is now fragmented in three parts, about 3kb, 4kb, and 5kb in length and cloned in TA cloning plasmids. These fragments will be cut with enzyme and ligated each other to form one-full-length cDNA.Currently, we are working in that process. We were able to find a BAG clone containing the gene, and we direct-sequence the clone by large-scale preparation of the BAG clone. The gene turned out to be composed of 49 exons. We designed oligonucleotides for amplifying each exon. Mutation analysis of a patient with CHS, which I previously reported in the Journal of Dermatology in 1993, was performed by PCR-SSCP and direct sequencing. We found a 4 bp-deletion encompassing codon 3464-3465, which results in frameshift. Being inbred, the patient was homozygous for that mutation and the parents were heterozygous for that mutation.Thus we were able to clone the whole coding region of the gene for CHS.We are going to sub-clone the gene to mammalian expression vector and functional analysis of the gene. I believe that this study will be a critical step for the future gene therapy of this fatal disorder.
眼皮白化病,许多细胞类型中的巨型包容体,免疫缺陷是Chediak-Higashi综合征(CHS)的特征。 Previously, others and we have mapped and cloned the gene for human CHS.In this study, we aimed to clone the whole gene and characterize the intron-exon organization of the gene and mutation analysis of the disorder.By marathon cDNA amplification method, we succeeded in cloning the whole gene for CHS.The gene is now fragmented in three parts, about 3kb, 4kb, and 5kb in length and cloned in TA cloning质粒。这些片段将用酶切割,并互相结扎以形成一饱长的cDNA。目前,我们正在该过程中工作。我们能够找到一个包含该基因的袋子克隆,并通过大规模准备袋子克隆来指导克隆。原来该基因由49个外显子组成。我们设计了用于扩增每个外显子的寡核苷酸。我先前在1993年的皮肤病学杂志上报告的CHS患者的突变分析是通过PCR-SSCP和直接测序进行的。我们发现了一个4 bp-demotion包含密码子3464-3465,这导致了移交。该突变的患者近亲是纯合的,并且父母对该突变是杂合的。我认为,这项研究将是这种致命疾病的未来基因疗法的关键步骤。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
深井和吉: "細胞内小器官の構造異常にかかわる遺伝子" 実験医学. 15巻6号. 635-637 (1997)
Kazuyoshi Fukai:“参与细胞内细胞器结构异常的基因”,《实验医学》,第 15 卷,第 6 期,635-637(1997 年)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUKAI Kazuyoshi其他文献

FUKAI Kazuyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUKAI Kazuyoshi', 18)}}的其他基金

Mutation analysis of filaggrin gene in Japanese patients with atopic dermatitis
日本特应性皮炎患者丝聚蛋白基因突变分析
  • 批准号:
    19591324
  • 财政年份:
    2007
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of methylation status of the promoter of the IRF2 gene, a candidate gene for psoriasis
银屑病候选基因IRF2基因启动子甲基化状态分析
  • 批准号:
    17591180
  • 财政年份:
    2005
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoter analysis of the interferon regulatory factor 2 and the SNP analysis of the gene
干扰素调节因子2启动子分析及基因SNP分析
  • 批准号:
    15591187
  • 财政年份:
    2003
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promoter analysis of IL-4R gene and its possible associateion of atopic dermatitis
IL-4R基因启动子分析及其与特应性皮炎的可能关系
  • 批准号:
    13670897
  • 财政年份:
    2001
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
HPS1 GENE : ITS MUTATION AND FUNCTION
HPS1 基因:其突变和功能
  • 批准号:
    11670846
  • 财政年份:
    1999
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

原发性免疫缺陷病中CD8+T细胞衰老的分子机制研究
  • 批准号:
    82330051
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
Wiskott-Aldrich综合征中的免疫缺陷:WASH蛋白在B细胞中的功能
  • 批准号:
    32311530061
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    国际(地区)合作与交流项目
新GII.4[P16]诺如病毒在免疫缺陷患儿治疗中的准种演变规律研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于prime editing基因编辑小鼠造血干细胞治疗重症联合免疫缺陷的研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
非典型性CARD11突变导致先天性免疫缺陷的全新分子机制研究
  • 批准号:
    82171850
  • 批准年份:
    2021
  • 资助金额:
    53 万元
  • 项目类别:
    面上项目

相似海外基金

Genome editing-based gene therapy for primary immunodeficiency caused by dominant gain-of-function mutations.
基于基因组编辑的基因治疗,用于治疗由显性功能获得性突变引起的原发性免疫缺陷。
  • 批准号:
    19K08312
  • 财政年份:
    2019
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Solving delivery of gene therapy for control of Human Immunodeficiency Virus infection
解决控制人类免疫缺陷病毒感染的基因治疗的问题
  • 批准号:
    nhmrc : GNT1128012
  • 财政年份:
    2017
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Project Grants
Solving delivery of gene therapy for control of Human Immunodeficiency Virus infection
解决控制人类免疫缺陷病毒感染的基因治疗的问题
  • 批准号:
    nhmrc : 1128012
  • 财政年份:
    2017
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Project Grants
Innovative mathematical modelling to determine incorporation of gene therapy in different cell lineages; Human Immunodeficiency Virus (HIV) as a model setting
创新的数学模型,以确定基因治疗在不同细胞谱系中的结合;
  • 批准号:
    LP130100015
  • 财政年份:
    2013
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Linkage Projects
Clinical trial of self-inactivating vectors for gene therapy of X-linked Severe Combined Immunodeficiency (SCID-X1)
自失活载体用于X连锁严重联合免疫缺陷症(SCID-X1)基因治疗的临床试验
  • 批准号:
    G0501969/1
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了